Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
50.0%
% of PPH's 27 holdings also in XPH
29.3%
% of XPH's 41 holdings also in PPH
Overlap by Weight
Sector Drift (PPH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PPH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
PFIZER INC | 4.9% | 4.1% | 4.1% |
|
JOHNSON & JOHNSON | 6.3% | 4.0% | 4.0% |
|
ZOETIS INC | 4.6% | 3.9% | 3.9% |
|
BRISTOL-MYERS SQUIBB CO | 4.5% | 3.9% | 3.9% |
|
ELI LILLY & CO | 12.5% | 3.7% | 3.7% |
Position Highlights (Non-Overlapping Exposures)
PPH Overweight Relative to XPH
 |
NOVO-NORDISK A/S-SPONS ADR | 9.3% |
|
ELI LILLY & CO | 8.9% |
|
ABBVIE INC | 5.5% |
 |
NOVARTIS AG-ADR | 5.0% |
 |
ASTRAZENECA PLC-SPONS ADR | 4.9% |
 |
SANOFI-AVENTIS-ADR | 4.7% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | 4.5% |
|
MCKESSON CORP | 4.5% |
|
AMERISOURCEBERGEN CORP | 4.4% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 4.3% |
PPH Underweight Relative to XPH
|
AXSOME THERAPEUTICS, INC. | -4.3% |
|
INTRA-CELLULAR THERAPIES INC | -4.1% |
|
ROYALTY PHARMA PLC CLASS A | -3.9% |
|
CORCEPT THERAPEUTICS INC | -3.6% |
|
ARVINAS, INC. | -3.5% |
 |
PERRIGO CO | -3.4% |
|
ORGANON & CO. | -3.1% |
|
CATALENT INC | -3.1% |
|
JAZZ PHARMACEUTICALS PLC | -2.6% |
|
OCULAR THERAPEUTIX INC | -2.6% |